335 related articles for article (PubMed ID: 37511937)
1. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution.
Cesario S; Genovesi V; Salani F; Vasile E; Fornaro L; Vivaldi C; Masi G
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511937
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation.
Saleh Y; Abu Hejleh T; Abdelrahim M; Shamseddine A; Chehade L; Alawabdeh T; Mohamad I; Sammour M; Turfa R
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893200
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
Jiang J; Huang H; Chen R; Lin Y; Ling Q
Front Immunol; 2023; 14():1092401. PubMed ID: 36875077
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt.
Shaker MK; Montasser IF; Sakr M; Elgharib M; Dabbous HM; Ebada H; Dorry AE; Bahaa M; Meteini ME
J Hepatocell Carcinoma; 2018; 5():29-36. PubMed ID: 29520343
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.
Luo Y; Teng F; Fu H; Ding GS
World J Gastrointest Oncol; 2022 Jan; 14(1):163-180. PubMed ID: 35116109
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation.
Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):143-50. PubMed ID: 21459720
[TBL] [Abstract][Full Text] [Related]
7. The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.
Ziogas IA; Evangeliou AP; Giannis D; Hayat MH; Mylonas KS; Tohme S; Geller DA; Elias N; Goyal L; Tsoulfas G
Oncologist; 2021 Jun; 26(6):e1036-e1049. PubMed ID: 33314549
[TBL] [Abstract][Full Text] [Related]
8. When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road.
Gu Y; Xu S; Wang Z; Yang J; Zheng S; Wei Q; Liu Z; Xu X
Chin J Cancer Res; 2023 Apr; 35(2):92-107. PubMed ID: 37180832
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors in liver transplant: a case series.
Rudolph M; Shah SA; Quillin R; Lemon K; Olowokure O; Latif T; Sohal D
J Gastrointest Oncol; 2023 Apr; 14(2):1141-1148. PubMed ID: 37201081
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.
Katariya NN; Lizaola-Mayo BC; Chascsa DM; Giorgakis E; Aqel BA; Moss AA; Uson Junior PLS; Borad MJ; Mathur AK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565184
[TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.
Gao Q; Anwar IJ; Abraham N; Barbas AS
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944927
[TBL] [Abstract][Full Text] [Related]
12. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
Lei JY; Yan LN; Wang WT
World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
[TBL] [Abstract][Full Text] [Related]
13. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies.
Tan DJH; Lim WH; Yong JN; Ng CH; Muthiah MD; Tan EX; Xiao J; Lim SY; Pin Tang AS; Pan XH; Kabir T; Bonney GK; Sundar R; Syn N; Kim BK; Dan YY; Noureddin M; Loomba R; Huang DQ
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1475-1484. PubMed ID: 35181565
[TBL] [Abstract][Full Text] [Related]
14. When to consider liver transplantation in hepatocellular carcinoma patients?
Ma KW; Cheung TT
Hepat Oncol; 2017 Jan; 4(1):15-24. PubMed ID: 30191050
[TBL] [Abstract][Full Text] [Related]
15. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View.
Abdelrahim M; Esmail A; Saharia A; Abudayyeh A; Abdel-Wahab N; Diab A; Murakami N; Kaseb AO; Chang JC; Gaber AO; Ghobrial RM
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406533
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplantation after Successful Downstaging of a Locally Advanced Hepatocellular Carcinoma with Systemic Therapy.
Schmiderer A; Zoller H; Niederreiter M; Effenberger M; Oberhuber G; Krendl FJ; Oberhuber R; Schneeberger S; Tilg H; Djanani A
Dig Dis; 2023; 41(4):641-644. PubMed ID: 36646054
[TBL] [Abstract][Full Text] [Related]
17. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
18. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation.
Ouranos K; Chatziioannou A; Goulis I; Sinakos E
World J Transplant; 2022 Nov; 12(11):331-346. PubMed ID: 36437845
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hepatic tumors: a systematic review.
Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
